Tuberculosis: all 1,435 studies
Page 10 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TBCompletedNCT02619240
- FS-1 Drug for Treatment of Multiple Drug-resistant TuberculosisCompletedNCT02607449Phase 3
- A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult SubjectsTerminatedNCT02606214Phase 1
- Hepatitis B in Cystic Fibrosis and Latent Tuberculosis RespectivelyWithdrawnNCT02605538Not applicable
- Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy VolunteersCompletedNCT02602509Phase 1
- Biomarkers for Therapy Response in Drug-resistant TuberculosisCompletedNCT02597621
- Improving Quality by Maintaining Accurate Problems in the EHRCompletedNCT02596087Not applicable
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)CompletedNCT02589782Phase 2/3
- The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous MeningitisStatus unknownNCT02588196Phase 4
- Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis InfectionCompletedNCT02581579Not applicable
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary TuberculosisCompletedNCT02581527Phase 3
- Evaluation of an Innovative Tuberculosis Diagnostic TestStatus unknownNCT02573623
- Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight DistanceCompletedNCT02558842Not applicable
- Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected PersonsCompletedNCT02538952Phase 4
- Evaluation of South Africa's National Adherence StrategyCompletedNCT02536768Not applicable
- Sputum Pharmacokinetics of TB Drugs and Bacterial Drug ResistanceCompletedNCT02534727
- Screening for TB in Pregnancy. on HIV-Infected Pregnant WomenCompletedNCT02520973Not applicable
- Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis InfectionCompletedNCT02512939Not applicable
- Improving the Detection of Active Tuberculosis in Accident and Emergency DepartmentsStatus unknownNCT02512484
- DNA Sequencing of MDR TB in Eastern SiberiaStatus unknownNCT02508610
- Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult SubjectsCompletedNCT02508376Phase 1
- Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis PandemicCompletedNCT02503839Phase 1
- Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis VaccineCompletedNCT02501421Phase 1
- Yield of Cryoprobe vs Flexible Forceps Pleural BiopsyCompletedNCT02500277Not applicable
- Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA SamplesStatus unknownNCT02497079Not applicable
- Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in UzbekistanStatus unknownNCT02496572
- 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CTCompletedNCT02481726Phase 1/2
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal TuberculosisStatus unknownNCT02477852Phase 4
- Efficacy of HUEXC030 in Subjects With Pulmonary TuberculosisCompletedNCT02467608Phase 2/3
- Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution TuberculosisStatus unknownNCT02464683Phase 4
- PK Study of Anti-TB DrugsCompletedNCT02457208Phase 1
- Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis ContactsCompletedNCT02454738Not applicable
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant TuberculosisCompletedNCT02454205Phase 2/3
- A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TBCompletedNCT02430506Phase 1
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis PreventionCompletedNCT02430259Phase 3
- A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive AdultsCompletedNCT02420444Phase 1
- Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice WeeklyCompletedNCT02415985Phase 2
- Nosocomial Transmission of MDR-TB in Bucharest, RomaniaCompletedNCT02413931
- Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the USCompletedNCT02413502Early Phase 1
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy VolunteersCompletedNCT02393586Phase 1
- Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South AfricaCompletedNCT02391415Phase 2
- Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65CompletedNCT02389322Phase 2
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy VolunteersSuspendedNCT02387242Phase 1
- IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight InfantsCompletedNCT02383849
- A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, RomaniaCompletedNCT02382107
- Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel BiomarkersCompletedNCT02381470Phase 2
- Heterologous Effects of BCG in Healthy UK AdultsCompletedNCT02380508Not applicable
- A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402CompletedNCT02375256Phase 1
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in TuberculosisCompletedNCT02371681Phase 2
- An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)CompletedNCT02365623Phase 2
- Finding and Treating Unsuspected and Resistant TB to Reduce Hospital TransmissionStatus unknownNCT02355223Not applicable
- Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary TuberculosisCompletedNCT02349841Phase 2
- Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TBCompletedNCT02348177Phase 4
- Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by AerosolCompletedNCT02337270Phase 1
- Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02336542Phase 2
- Research on New Regimens for Retreatment Pulmonary TuberculosisStatus unknownNCT02331823Phase 4
- Virtually Observed Treatment (VOT) for Tuberculosis Patients in MoldovaStatus unknownNCT02331732Not applicable
- Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?CompletedNCT02331056
- Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary TuberculosisCompletedNCT02313610Phase 2
- Test and Treat TB: A Proof of Concept Trial in South AfricaCompletedNCT02298309Not applicable
- A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult SubjectsCompletedNCT02288481Phase 1
- Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From GhanaCompletedNCT02281643Phase 2
- A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)CompletedNCT02279875Phase 2
- Vitamin D Supplementation in TB PreventionCompletedNCT02276755Phase 3
- A Prospective Patient Registry of Patients Exposed to BedaquilineCompletedNCT02274389
- Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active TuberculosisCompletedNCT02273765Phase 3
- Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification TestsCompletedNCT02252198
- Feasibility and Accuracy of a Novel Xpert CartridgeCompletedNCT02251327
- Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in SputumStatus unknownNCT02245347
- A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment OutcomesCompletedNCT02238405Not applicable
- A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous MeningitisCompletedNCT02237365Phase 2
- Brief Bactericidal Activity of Anti-Tuberculosis DrugsCompletedNCT02236078Phase 1
- Rewards for Tuberculosis Contact ScreeningCompletedNCT02234908Not applicable
- Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment InitiationCompletedNCT02231229Phase 4
- Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth InfectionTerminatedNCT02225158
- ENOSE in Pulmonary Tuberculosis in YogyakartaCompletedNCT02219945Not applicable
- PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)CompletedNCT02216331Phase 1
- Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in TaiwanStatus unknownNCT02208427Phase 3
- Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African AdolescentsCompletedNCT02178748Phase 2
- Iron Absorption and Utilization During Tuberculosis and After TreatmentCompletedNCT02176772
- Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network AnalysisCompletedNCT02175849
- IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous PeritonitisTerminatedNCT02175134Not applicable
- Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control ProgramStatus unknownNCT02174380Not applicable
- Global Consortium for Drug-resistant Tuberculosis DiagnosticsCompletedNCT02170441
- High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding StudyCompletedNCT02169882Phase 2/3
- Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary TuberculosisStatus unknownNCT02169570Phase 4
- Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis PatientsCompletedNCT02169141
- Establishment of a Clinical Trial Unit in Mavalane, Maputo, in MozambiqueCompletedNCT02156882
- The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMIDCompletedNCT02135289
- Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis AgentsCompletedNCT02128308Phase 1
- Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus)CompletedNCT02127983Not applicable
- HRZE Fasted/Fed in Newly Diagnosed TBCompletedNCT02121314Phase 2
- Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of PyrazinamideStatus unknownNCT02120638Phase 3
- Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South AfricaCompletedNCT02119130Not applicable
- Labial Biopsy in Patients With Tuberculosis DiseaseCompletedNCT02115854
- A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)CompletedNCT02109874Phase 1
- Pulmonary Tuberculosis Patients With Diabetes MellitusCompletedNCT02106039Not applicable
- Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972)CompletedNCT02097095
- A Clinical Challenge Study of BCG in Healthy VolunteersCompletedNCT02088892Not applicable
- Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From TuberculosisCompletedNCT02076139Not applicable